Shengye Liu

420 total citations
22 papers, 306 citations indexed

About

Shengye Liu is a scholar working on Molecular Biology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Shengye Liu has authored 22 papers receiving a total of 306 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 7 papers in Cancer Research and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Shengye Liu's work include Bone Metabolism and Diseases (6 papers), Ferroptosis and cancer prognosis (3 papers) and Angiogenesis and VEGF in Cancer (3 papers). Shengye Liu is often cited by papers focused on Bone Metabolism and Diseases (6 papers), Ferroptosis and cancer prognosis (3 papers) and Angiogenesis and VEGF in Cancer (3 papers). Shengye Liu collaborates with scholars based in China and United States. Shengye Liu's co-authors include Liyu Yang, Qin Fu, Shuai Mu, Bin Wu, Tao Fang, Jiamei Liu, Long Zhou, Zhiguang Chen, Jiamei Liu and Ran Guo and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Life Sciences and Oncotarget.

In The Last Decade

Shengye Liu

20 papers receiving 304 citations

Peers

Shengye Liu
Hyun‐Ju An South Korea
Yiming Li China
Xifeng Xiong China
Zenong Yuan China
Daqian Wan China
Junjie Niu China
Zhong-Hua Chen China
Hyun‐Ju An South Korea
Shengye Liu
Citations per year, relative to Shengye Liu Shengye Liu (= 1×) peers Hyun‐Ju An

Countries citing papers authored by Shengye Liu

Since Specialization
Citations

This map shows the geographic impact of Shengye Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengye Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengye Liu more than expected).

Fields of papers citing papers by Shengye Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shengye Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengye Liu. The network helps show where Shengye Liu may publish in the future.

Co-authorship network of co-authors of Shengye Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Shengye Liu. A scholar is included among the top collaborators of Shengye Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shengye Liu. Shengye Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Jiamei, Qiuwen Wu, Xue Cai, et al.. (2025). The role of NRF2 in human cancers: Pre-clinical insights paving the way for clinical trials. Journal of Pharmaceutical Analysis. 101358–101358.
2.
Liu, Jiamei, et al.. (2025). The role of multi-omics in biomarker discovery, diagnosis, prognosis, and therapeutic monitoring of tissue repair and regeneration processes. Journal of Orthopaedic Translation. 54. 131–151. 3 indexed citations
3.
Liu, Shengye, et al.. (2025). Comparative efficacy of robotic exoskeleton and conventional gait training in patients with spinal cord injury: a meta-analysis of randomized controlled trials. Journal of NeuroEngineering and Rehabilitation. 22(1). 121–121. 2 indexed citations
4.
5.
Yang, Liyu, Jiamei Liu, & Shengye Liu. (2023). Clinical significance and immune landscape of a novel ferroptosis-related prognosis signature in osteosarcoma. BMC Cancer. 23(1). 229–229. 7 indexed citations
6.
Yang, Liyu, et al.. (2023). A novel signature of autophagy-related immunophenotyping biomarkers in osteoarthritis. Life Sciences. 321. 121599–121599. 3 indexed citations
7.
Mu, Shuai, Yang Xia, Qi‐Jun Wu, et al.. (2021). Response of Bone Metabolism Markers to Ice Swimming in Regular Practitioners. Frontiers in Physiology. 12. 731523–731523. 6 indexed citations
8.
Liu, Jiamei, Shengye Liu, & Xianghong Yang. (2021). Construction of Gene Modules and Analysis of Prognostic Biomarkers for Cervical Cancer by Weighted Gene Co-Expression Network Analysis. Frontiers in Oncology. 11. 542063–542063. 10 indexed citations
9.
Yang, Liyu, Shengye Liu, Shuai Mu, et al.. (2021). Paeoniflorin Attenuates Dexamethasone-Induced Apoptosis of Osteoblast Cells and Promotes Bone Formation via Regulating AKT/mTOR/Autophagy Signaling Pathway. Evidence-based Complementary and Alternative Medicine. 2021. 1–12. 29 indexed citations
10.
Liu, Jiamei, Liyu Yang, Qin Fu, & Shengye Liu. (2020). Emerging Roles and Potential Biological Value of CircRNA in Osteosarcoma. Frontiers in Oncology. 10. 552236–552236. 24 indexed citations
11.
Liu, Shengye, Jiamei Liu, Xuechen Yu, Tao Shen, & Qin Fu. (2020). Identification of a Two-Gene (PML-EPB41) Signature With Independent Prognostic Value in Osteosarcoma. Frontiers in Oncology. 9. 1578–1578. 8 indexed citations
12.
Liu, Jiamei, Qin Fu, & Shengye Liu. (2020). Transcriptional Regulation Based on Network of Autophagy Identifies Key Genes and Potential Mechanisms in Human Osteoarthritis. Cartilage. 13(2_suppl). 1431S–1441S. 5 indexed citations
13.
Wang, Wenhui, et al.. (2020). Predictive value of serum VEGF, IL‑1 and TNF‑α in the treatment of thromboangiitis obliterans by revascularization. Experimental and Therapeutic Medicine. 20(6). 1–1. 5 indexed citations
14.
Yang, Liyu, et al.. (2019). Arbutin promotes MC3T3‑E1 mouse osteoblast precursor cell proliferation and differentiation via the Wnt/β‑catenin signaling pathway. Molecular Medicine Reports. 19(6). 4637–4644. 16 indexed citations
15.
Yang, Liyu, Shengye Liu, Shuai Mu, et al.. (2018). Leonurine hydrochloride promotes osteogenic differentiation and increases osteoblastic bone formation in ovariectomized mice by Wnt/β-catenin pathway. Biochemical and Biophysical Research Communications. 504(4). 941–948. 12 indexed citations
16.
Liu, Shengye, Liyu Yang, Shuai Mu, & Qin Fu. (2018). Epigallocatechin-3-Gallate Ameliorates Glucocorticoid-Induced Osteoporosis of Rats in Vivo and in Vitro. Frontiers in Pharmacology. 9. 447–447. 31 indexed citations
17.
Liu, Shengye, et al.. (2018). Different doses of folic acid and vitamin B12 to treat rabbits with deep venous thrombosis and hyperhomocysteinemia. Experimental and Therapeutic Medicine. 15(3). 2874–2878. 4 indexed citations
18.
Liu, Shengye, Tao Fang, Liyu Yang, et al.. (2018). Gastrodin protects MC3T3-E1 osteoblasts from dexamethasone-induced cellular dysfunction and promotes bone formation via induction of the NRF2 signaling pathway. International Journal of Molecular Medicine. 41(4). 2059–2069. 43 indexed citations
19.
Liu, Shengye, et al.. (2016). TRIM29 Overexpression Promotes Proliferation and Survival of Bladder Cancer Cells through NF-κB Signaling. Cancer Research and Treatment. 48(4). 1302–1312. 46 indexed citations
20.
Wu, Qianqian, et al.. (2016). Shikonin stimulates MC3T3-E1 cell proliferation and differentiation via the BMP-2/Smad5 signal transduction pathway. Molecular Medicine Reports. 14(2). 1269–1274. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hyun‐Ju An Breakdown of academic impact, for papers by Yiming Li Breakdown of academic impact, for papers by Xifeng Xiong Breakdown of academic impact, for papers by Zenong Yuan Breakdown of academic impact, for papers by Daqian Wan Breakdown of academic impact, for papers by Junjie Niu Breakdown of academic impact, for papers by Zhong-Hua Chen
Rankless by CCL
2026